With societal development and accelerated population aging in China, the demand for high-quality nursing services continues to grow, placing the nursing sector in a dual scenario of challenges and opportunities that necessitate parallel advancements in development and reform. Clinical practice guidelines (CPGs), as critical tools for enhancing nursing quality and standardizing evidence-based care, face multifaceted challengesincluding complexities in evidence integration, methodological and reporting irregularities, barriers to multidisciplinary collaboration, and suboptimal clinical adherence. However, emerging opportunities—such as optimized methodological frameworks, the application of implementation science, and the integration of digital and intelligent technologies—are creating new pathways for advancing high-quality nursing practice. This article elaborates on the necessity of developing rigorous nursing CPGs and analyzes the current opportunities and challenges in their formulation, dissemination, and implementation, aiming to provide theoretical insights for strengthening guideline-driven nursing care.

OBJECTIVEThe sex therapy is not yet popularized at present. This study aimed to evaluate the effect of the combination of the improved sex therapy and oral sildenafil on erectile dysfunction (ED).

METHODSA total of 3130 Uigur cases of ED received in Xinjiang Bogda Hospital were divided into a control group (n=625) and a trial group (n=2505), the former treated with oral sildenafil alone, and the latter by the combination of the improved genital therapy and sildenafil, both for 3 months and followed up at 6 and 12 months after the treatment. The therapeutic effects were evaluated and compared using IIEF-5.

RESULTSThe IIEF-5 scores of the control group were 12.80 +/- 3.76 and 18.10 +/- 2.61 before and after the treatment, and 17.35 +/- 2.73 and 16.64 +/- 2.63 at 6 and 12 months, respectively, while those of the trial group were 12.73 +/- 3.52 and 19.06 +/- 4.07 before and af- ter the treatment, and 19.86 +/- 2.42 and 20.47 +/- 2.38 at 6 and 12 months, respectively, with statistically significant differences either between pre- and post-treatment (P < 0.05) or between the control and trial groups at 6 and 12 months (P < 0.05).

CONCLUSIONThe combination of the improved sex therapy and oral sildenafil is superior to sildenafil alone in the treatment of ED, and its efficacy is relatively stable at 12 months.

Adult ; Aged ; Asian Continental Ancestry Group ; Erectile Dysfunction ; drug therapy ; ethnology ; Humans ; Male ; Middle Aged ; Piperazines ; therapeutic use ; Purines ; therapeutic use ; Retrospective Studies ; Sildenafil Citrate ; Sulfones ; therapeutic use ; Treatment Outcome ; Young Adult